Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 279

1.

Endometrial endometrioid adenocarcinoma: a pathologic analysis of 827 consecutive cases.

Nofech-Mozes S, Ghorab Z, Ismiil N, Ackerman I, Thomas G, Barbera L, Covens A, Khalifa MA.

Am J Clin Pathol. 2008 Jan;129(1):110-4.

PMID:
18089496
2.

Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.

Orezzoli JP, Sioletic S, Olawaiye A, Oliva E, del Carmen MG.

Gynecol Oncol. 2009 Jun;113(3):316-23. doi: 10.1016/j.ygyno.2009.03.007. Epub 2009 Apr 5.

PMID:
19345400
3.

Staining characterization by immunohistochemistry of tumor cancer antigen in patients with endometrial cancer.

Metindir J, Dilek GB, Pak I.

Eur J Gynaecol Oncol. 2008;29(5):489-92.

PMID:
19051819
4.

Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.

Ismiil N, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Ackerman I, Thomas G, Covens A, Khalifa MA.

Ann Diagn Pathol. 2007 Aug;11(4):252-7.

PMID:
17630108
5.

Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.

Espinosa I, José Carnicer M, Catasus L, Canet B, D'angelo E, Zannoni GF, Prat J.

Am J Surg Pathol. 2010 Nov;34(11):1708-14. doi: 10.1097/PAS.0b013e3181f32168.

PMID:
20962622
6.

Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium.

Desrosiers L, Fadare O, Xiao ZF, Dresser K, Wang SA.

Ann Diagn Pathol. 2008 Apr;12(2):112-7. doi: 10.1016/j.anndiagpath.2007.05.009. Epub 2007 Oct 24.

PMID:
18325471
7.

Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma.

Nofech-Mozes S, Ackerman I, Ghorab Z, Ismiil N, Thomas G, Covens A, Khalifa MA.

Am J Clin Pathol. 2008 Jun;129(6):912-7. doi: 10.1309/CP3HGX7H753QQU8T.

PMID:
18480008
8.

The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.

Chi DS, Barakat RR, Palayekar MJ, Levine DA, Sonoda Y, Alektiar K, Brown CL, Abu-Rustum NR.

Int J Gynecol Cancer. 2008 Mar-Apr;18(2):269-73. doi: 10.1111/j.1525-1438.2007.00996.x.

PMID:
18334008
9.

Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.

Ismiil ND, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Thomas G, Ackerman I, Covens A, Khalifa MA.

Int J Gynecol Pathol. 2007 Jul;26(3):278-83.

PMID:
17581412
10.

[Multivariate analysis of prognostic factors in endometrial carcinoma].

Li B, Wu LY, Li SM, Zhang WH, Zhang R, Ma SK.

Ai Zheng. 2004 Sep;23(9):1085-8. Chinese.

PMID:
15363208
11.

The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma.

Euscher E, Fox P, Bassett R, Al-Ghawi H, Ali-Fehmi R, Barbuto D, Djordjevic B, Frauenhoffer E, Kim I, Hong SR, Montiel D, Moschiano E, Roma A, Silva E, Malpica A.

Am J Surg Pathol. 2013 Nov;37(11):1728-36. doi: 10.1097/PAS.0b013e318299f2ab.

12.

Predictors of final histology in patients with endometrial cancer.

Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, Bodurka DC.

Gynecol Oncol. 2004 Dec;95(3):463-8.

PMID:
15581947
13.

The clinical value of preoperative and intraoperative assessments in the management of endometrial cancer.

Celik C, Ozdemir S, Esen H, Balci O, Ylmaz O.

Int J Gynecol Cancer. 2010 Apr;20(3):358-62. doi: 10.1111/IGC.0b013e3181cff1f3.

PMID:
20375797
14.

Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer.

Kondalsamy-Chennakesavan S, van Vugt S, Sanday K, Nicklin J, Land R, Perrin L, Crandon A, Obermair A.

Int J Gynecol Cancer. 2010 Oct;20(7):1217-21.

PMID:
21495232
15.

Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.

Soeda S, Nakamura N, Ozeki T, Nishiyama H, Hojo H, Yamada H, Abe M, Sato A.

Gynecol Oncol. 2008 Apr;109(1):122-8. doi: 10.1016/j.ygyno.2007.12.033. Epub 2008 Mar 4.

PMID:
18289648
16.

Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.

Schwab KV, O'Malley DM, Fowler JM, Copeland LJ, Cohn DE.

Gynecol Oncol. 2009 Jan;112(1):146-9. doi: 10.1016/j.ygyno.2008.09.009. Epub 2008 Oct 19.

PMID:
18937970
17.

High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.

Sonoda Y, Zerbe M, Smith A, Lin O, Barakat RR, Hoskins WJ.

Gynecol Oncol. 2001 Mar;80(3):378-82.

PMID:
11263935
18.

Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion.

Quick CM, May T, Horowitz NS, Nucci MR.

Int J Gynecol Pathol. 2012 Jul;31(4):337-43. doi: 10.1097/PGP.0b013e31823ff422.

PMID:
22653347
19.

Intraoperative gross assessment of myometrial invasion and cervical involvement in endometrial cancer: Role of tumor grade and size.

Fotiou S, Vlahos N, Kondi-Pafiti A, Zarganis P, Papakonstantinou K, Creatsas G.

Gynecol Oncol. 2009 Mar;112(3):517-20. doi: 10.1016/j.ygyno.2008.11.009. Epub 2008 Dec 30.

PMID:
19117598
20.

The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.

Lee KB, Ki KD, Lee JM, Lee JK, Kim JW, Cho CH, Kim SM, Park SY, Jeong DH, Kim KT.

Ann Surg Oncol. 2009 Oct;16(10):2882-7. doi: 10.1245/s10434-009-0535-0. Epub 2009 May 30.

PMID:
19484311

Supplemental Content

Support Center